Acton, MA, United States of America

Carl Ralph Flannery

USPTO Granted Patents = 7 


Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Carl Ralph Flannery: Innovator in Recombinant Lubricin Molecules

Introduction

Carl Ralph Flannery is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant lubricin molecules. With a total of 7 patents, Flannery's work has the potential to impact various medical applications.

Latest Patents

Flannery's latest patents include innovative polynucleotides encoding recombinant lubricin molecules. These molecules serve as lubricants, anti-adhesive agents, and intra-articular supplements for various anatomical structures, such as synovial joints, meniscus, tendon, peritoneum, pericardium, and pleura. His work in this area highlights the versatility and importance of recombinant lubricin in medical treatments.

Career Highlights

Throughout his career, Flannery has worked with prominent companies in the pharmaceutical industry, including Wyeth and Pfizer Corporation. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical science.

Collaborations

Flannery has collaborated with several professionals in his field, including Christopher John Corcoran and Lisa Anne Collins-Racie. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Carl Ralph Flannery's contributions to the field of biotechnology, particularly through his patents on recombinant lubricin molecules, demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…